Tag Archives: biotechnology law

EPO – New Guidance On Added Subject Matter

Posted on October 9, 2014 by Warren Woessner

A guest post from Paul Cole. Readers will be aware that added subject matter issues have for a long time been a thorny issue for EPO Examination practice. On 7 February 2014 a symposium on EPO practice regarding Art. 123(2) … Continue reading →

Posted in EP and UK Practice | Tagged , , , , , | Leave a comment

“The Good Wife” Defends GMOs

Posted on October 7, 2014 by Warren Woessner

Last Sunday’s episode of “The Good Wife” featured a Christian mediation between a farmer (Robert Joy) sued by a Pioneer-like company, represented by the actor Richard Thomas, for saving GMO corn seed for replanting. The facts were a mash-up of … Continue reading →

Posted in Ag Biotechnology, Patent Eligible Subject Matter | Tagged , , , , , , , , , | Leave a comment

American Calcar v. Amer. Honda Motor Co. – Therasense Goes Out For a Test Drive

Posted on September 30, 2014 by Warren Woessner

On Friday, in American Calcar v. Amer. Honda Motor Co., App. No. 2013-1061 (Fed. Cir., September 26, 2014) a divided Fed. Cir. panel affirmed the district court’s ruling, following remand, that three patents on a multimedia system for vehicle information … Continue reading →

Posted in Inequitable Conduct/Rule 56 | Tagged , , , , , , , | 1 Comment

Australia: Cancer Voices v Myriad Opinion Affirmed

Posted on September 5, 2014 by Warren Woessner

This is a guest post from Paul Cole. An opinion was handed down earlier today by the Federal Court of Australia – Full Court (Allsop C.J., Downsett, Kenny, Bennett and Middleton J.J., D’Arcy v Myriad Genetics Inc [2014] FCAFC 115 … Continue reading →

Posted in EP and UK Practice | Tagged , , , , , , , , | 2 Comments